HOUSTON & ENSCHEDE, Netherlands--(BUSINESS WIRE)--Stem Cell Innovations, Inc. (OTCBB:SCLL) announced today that the Company has initiated a collaboration with the University of Twente (the Netherlands) to explore the bone forming properties of PluriCells. Under the material transfer agreement, the University of Twente will get access to Stem Cell Innovations (SCI) proprietary human pluripotent stem cell technology and know-how. In return SCI will receive a nonexclusive license to intellectual property generated with the PluriCells.
